 |
BioWorld-Insight-2010-11-29
Inflammation in Cancer: Driving More than Tumors
A Deep Dive into Pfizer's Emerging Biotech Strategy
On Nov. 16, Pfizer Inc. announced a partnership with the University of California at San Francisco aimed at translating biotechnology discoveries into marketable drugs. It's the newest element of a multifaceted, R&D makeover that's designed to transform the New York-based pharmaceutical giant into a biotechnology powerhouse.
Biotech – Big Pharma Collaborations: Modified And Terminated Agreements, Oct. 1 - Nov. 23, 2010
No Abstract